4//SEC Filing
SAHAREK JOHN P. 4
Accession 0001493152-23-010884
CIK 0001360214other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 7:52 PM ET
Size
6.3 KB
Accession
0001493152-23-010884
Insider Transaction Report
Form 4
SAHAREK JOHN P.
CEO & President, ImprimisRx
Transactions
- Award
Restricted Stock Unit
2023-04-03+277,200→ 277,200 totalExp: 2028-04-03→ Common Stock (277,200 underlying)
Footnotes (1)
- [F1]Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan, as amended (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. The vesting of the PSUs (granted in lieu of service only stock option and restricted stock unit awards) require (i) a minimum of a two-year service period, and (ii) the achievement and maintenance of Harrow common stock price targets of $25 (causing the vesting of 39,600 PSU shares), $35 (causing the vesting of 59,400 PSU shares), $45 (causing the vesting of 79,200 PSU shares), $50 (causing the vesting of 99,000 PSU shares).
Documents
Issuer
HARROW HEALTH, INC.
CIK 0001360214
Entity typeother
Related Parties
1- filerCIK 0001632091
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 7:52 PM ET
- Size
- 6.3 KB